Share-based Payment Arrangement, Expense of CERO THERAPEUTICS HOLDINGS, INC. from 31 Mar 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
CERO THERAPEUTICS HOLDINGS, INC. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2023 to 30 Sep 2025.
  • CERO THERAPEUTICS HOLDINGS, INC. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $348,116, a 13% decline year-over-year.
  • CERO THERAPEUTICS HOLDINGS, INC. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $1,241,058.
  • CERO THERAPEUTICS HOLDINGS, INC. annual Share-based Payment Arrangement, Expense for 2024 was $924,668, a 854% increase from 2023.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

CERO THERAPEUTICS HOLDINGS, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,241,058 $348,116 -$51,884 -13% 01 Jul 2025 30 Sep 2025 10-Q 19 Nov 2025 2025 Q3
Q2 2025 $1,292,942 $183,328 +$153,328 +511% 01 Apr 2025 30 Jun 2025 10-Q 22 Aug 2025 2025 Q2
Q1 2025 $1,139,614 $304,946 +$214,946 +239% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $924,668 $404,668 01 Oct 2024 31 Dec 2024 10-K 15 Apr 2025 2024 FY
Q3 2024 $400,000 01 Jul 2024 30 Sep 2024 10-Q/A 20 Nov 2024 2024 Q3
Q2 2024 $30,000 -$1,370,000 -98% 14 Apr 2024 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $90,000 +$61,856 +220% 14 Feb 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q2 2023 $1,400,000 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 $28,144 01 Jan 2023 31 Mar 2023 10-Q 17 May 2024 2024 Q1

CERO THERAPEUTICS HOLDINGS, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $924,668 +$827,772 +854% 14 Feb 2024 31 Dec 2024 10-K 15 Apr 2025 2024 FY
2023 $96,896 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.